Valuation Active Biotech AB Nasdaq Stockholm
Stocks
ACTI
SE0001137985
Biotechnology & Medical Research
|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 5.300 SEK | 0.00% |
|
+2.12% | +15.22% |
| 08-20 | Active Biotech AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-20 | Active Biotech reports reduced operating loss | FW |
Company Valuation: Active Biotech AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 275.5 | 254.8 | 165.1 | 115.9 | 121.3 | 139.7 | - | - |
| Change | - | -7.51% | -35.2% | -29.8% | 4.6% | 15.22% | - | - |
| Enterprise Value (EV) | 223.1 | 254.8 | 128.9 | 88.53 | 121.3 | 139.7 | 139.7 | 139.7 |
| Change | - | 14.2% | -49.4% | -31.34% | 36.97% | 15.22% | 0% | 0% |
| P/E | - | - | - | - | - | - | - | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | - | - | - | -8.52x |
| EV / Revenue | - | - | - | - | - | - | - | -8.52x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -4.01x | 8.42x | 2.78x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -4.21x | 7.68x | 2.7x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | - | - | - | - | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | -16.4 |
| EBITDA 1 | -48.5 | -56.4 | -44.8 | -38.2 | -36 | -34.8 | 16.6 | 50.2 |
| EBIT 1 | -49.8 | -57.9 | -46.5 | -39.8 | -37.6 | -33.2 | 18.2 | 51.8 |
| Net income 1 | -49.8 | -58.4 | -45.8 | -39.4 | -37.32 | -33.2 | 18.2 | 51.8 |
| Net Debt | -52.37 | - | -36.2 | -27.4 | - | - | - | - |
| Reference price 2 | 126.400 | 96.200 | 45.650 | 10.880 | 4.600 | 5.300 | 5.300 | 5.300 |
| Nbr of stocks (in thousands) | 2,180 | 2,649 | 3,617 | 10,655 | 26,361 | 26,361 | - | - |
| Announcement Date | 3/25/22 | 2/9/23 | 2/8/24 | 2/13/25 | 4/1/26 | - | - | - |
1SEK in Million2
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.11x | 7.75x | 15.8x | 1.34% | 73.96B | |
| 36.85x | 9.53x | 29.23x | 0.04% | 64.66B | |
| -79.06x | 14.77x | -71.24x | -.--% | 27.32B | |
| -17.19x | 6.91x | -8.97x | -.--% | 27.86B | |
| 32.87x | 6.47x | 17.14x | -.--% | 25.97B | |
| 27.08x | 5.08x | 17.06x | -.--% | 19.98B | |
| 51.97x | 19.21x | 38.91x | 0.29% | 17.84B | |
| -1000000x | 41.19x | -1441.61x | -.--% | 16.24B | |
| 16.61x | 4.92x | 11.49x | -.--% | 13.3B | |
| Average | -111,100.97x | 12.87x | -154.69x | 0.19% | 31.9B | |
| Weighted average by Cap. | -56,560.79x | 10.91x | -72.87x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ACTI Stock
- ACTI Stock
- Valuation Active Biotech AB
Select your edition
All financial news and data tailored to specific country editions
